3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Obesity
45
Mucositis
29
Neoplasms
23
Sexual Dysfunction, Physiological
19
Head and Neck Neoplasms
16
Breast Neoplasms
16
Opioid-Induced Constipation
12
Dyspnea
11
Constipation
11
Pain
10
Polycystic Ovary Syndrome
9
Weight Loss
7
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
7
Motor Activity
7
Diabetes Mellitus
7
Cardiovascular Diseases
6
Xerostomia
5
Stomatitis
5
Radiation Injuries
5
Overweight
5
Sedentary Behavior
4
Endometrial Neoplasms
4
Diabetes Mellitus, Type 2
4
Colorectal Neoplasms
4
Bronchiolitis Obliterans Syndrome
4
Sexuality
3
Salivary Gland Neoplasms
3
Hypertension
3
Fatty Liver
3
Interventions
licogliflozin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Hyperandrogenism
×
Other
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts